Area of research
Pathology and Forensic Medicine · Oncology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Chronic Lymphocytic Leukemia Research, and Viral-associated cancers and disorders.
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma
Outcomes of <scp>CD19 CAR</scp>‐T therapy in central nervous system lymphoma: Insights from a multicentre experience
Updated results from a Phase II study of minimal residual disease-guided venetoclax + obinutuzumab for the initial treatment of fit patients with chronic lymphocytic leukemia
Dual-Targeted Therapy with Ruxolitinib Plus Duvelisib for T-Cell Lymphoma
Pembrolizumab Maintenance Instead of Autologous Hematopoietic Cell Transplantation for Patients with Relapsed or Refractory Hodgkin Lymphoma in Complete Response after Pembrolizumab, Gemcitabine, Vinorelbine, and Liposomal Doxorubicin
Pembrolizumab and Involved Site Radiation Therapy Alone As an Alternative to Transplant in Patients with Localized Failure Following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase II Study
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphoma
ENGINE: A Phase III Randomized Placebo Controlled Study of Enzastaurin/R-CHOP as Frontline Therapy in High-Risk Diffuse Large B-Cell Lymphoma Patients with the Genomic Biomarker DGM1
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era
Engine: Phase III Randomized Study of Enzastaurin/R-CHOP Versus Placebo/R-CHOP in Frontline High Risk Diffuse Large B Cell Lymphoma Patients with Novel Genomic Biomarker DGM1